Submission of Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026.

CIN: L27100TG1989PLC010122 ZENOTECH LABORATORIES LIMITED Registered Office & Factory: Survey No.250 -252 Turkapally Village, Genome Valley Road, Shamirpet Mandal Medchal-Malkajgiri Dist., Turkapalliyadaram, Hyderabad - 500 101 Telangana, India Tel: +91 90320 44584/ 585 Email: info@zenotech.co.in www.zenotechlab.com Date: October 28, 2026 BSE Limited Market Operations Dept., Phiroze Jeejeebhoy Towers Dalal Street Mumbai – 400 001 Scrip Code: 532039 Zenotech Laboratories Limited - Outcome of the Board Meeting held today i.e., October 28, 2026 Further to the communication dated October 17, 2026, pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), this is to inform that the Meeting of the Board of Directors of the Company (“Board”) was held today, i.e., October 28, 2026, which commenced at 12:00 P.M. IST/Noon and ended at 2:10 P.M. IST. The Board has, inter-alia, approved the Unaudited Standalone Financial Results for the quarter and half year ended September 30, 2026, as approved pursuant to Regulation 33 of the Listing Regulations, along with the Limited Review Report of the Statutory Auditors, are annexed herewith. For Zenotech Laboratories Limited (Abdul Gafoor Mohammad) Company Secretary & Compliance Officer ICSI Membership No.: A22331 Encl: as above GSKA & Co. 4th floor, Red building, Chartered Accountants Above Shinhan Bank, Boat Club Road, Pune-411 001 Independent Auditor's Review Report On Quarterly and Year to Date Standalone Financial Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended Review Report To The Board of Directors Zenotech Laboratories Limited I. We have reviewed the accompanying statement of unaudited standalone financial results of Zenotech Laboratories Limited (the "Company") for the quarter ended September 30,2026 and year to date from April 0 I , 2026 to September 30, 2026 (the "Statement") attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the "Listing Regulations"). 2. The Company's management is responsible for the preparation of the Statement in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, (lnd AS 34) "Interim Financial Reporting" prescribed under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. The Statement has been approved by the Company's Board of Directors. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standards ('Ind AS') specified under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. For G S K A & Co. Place of signature: Pune Date: October 28, 2026 ZENOTECH LABORATORIES LIMITED Cl:'i: L27100TG1989PLC010122 Survey :'io.250-252, Turkapally Village, Genome Valley Road, Shameerpet :\-Ianda I, Medchai-Malkajgiri District, Hyderabad-500101, Telangna Phone:+91 90320 44584/585 Website: www.zenotechlab.com Standalone Balance Sheet as at September 30, 2026 Rs in Lakhs As at As at Particulars 30 Seotember 2026 31 March 2026 (l"naudited) (Audited) ASSETS (I) :'lOon current assets (a) Property. plant and equ1pment 6.549 06 6.228 98 (b) Capital work-m-progress 269 54 360 33 (c) Financial assets (1) Investments (ii) Others 134 77 125 82 (d) Deferred tax assets (net) 16 14 (e) In co me tax assets 379 87 283 20 (f) Other non-current assets 38 56 13 09 Total non-current assets 7,387.94 7,011.42 (2) Current assets (a) Jnventones 155 40 (b) Fmancial assets (I) Trade receivables 187 07 877 68 (ii) Cash and cash equivalents 2,854 12 3,028 93 (1ii) Bank balances other than above 1349 13 49 (1v) Other financml asset 247 65 143 04 (c) Other current assets 141 89 40 79 Total current assets 3,599.62 4,103.93 TOTAL ASSETS 10,987.56 11,115.35 EQUITY AND LIABILITIES Equity (a} Equity share capital 6.103 06 6_103 06 (b) Other equity 3.109 29 3.409 05 Total equity 9,212.35 9,512.11 LIABILITIES (I) Non-current Liabilities (a) Financmlliabilities (i) Other financiall1abliities 101 97 97 25 (b) Other non current l1abiliues I 88 (c) Provisions 215 33 215 33 (d) Deferred tax liabilities (net) - 83,14 Total non-current liabilities 317.30 397.60 (2) Current Liabilities (a) Financial liabilities (i) Trade payables (a) Total outstanding dues of micro and small enterprises 129 82 51 81 (b) Total outstanding dues other than above 325 75 317 83 ( ii) Other financmlliabliilles 350 68 309 35 (b) Other current liabilities 166 40 7864 (c) Provisions 485 26 448 01 (d) Current tax liabilities (net) - . Total current liabilities 1,457.91 1,205.64 TOTAL EQUITY A"iD LIABILITIES 10,987.56 11,115.35 ZE~OTECH LABORATORIES LIMITED CJ~: L27100TGJ989PLC010122 Sun·ey i\'o.250-252. Tnr-kap~tlly Village-, Genome Valley Road, Shameerpel :\landal. \·ledchal-~lalkajgiri District, Hyderabad-500101, Telangna Phone:+91 90320 ~~58~1585 Websile: www.zenolerhlab.com Stalemenl of l'mtudited Slandalone Financial Results for the Quarler and Half Year ended 30 Seplember 2026 {RI in lnkhs~ except ~rnings ptr shnn•) Quarter ended I Half Year ended Year ended Sl. Puticulars 30.09.2026 30.06.2026 3o.o9.2025 I 30.09.2026 30.09.2025 31.03.2026 :"'o. l:naudited t:naudited Unaudited Unaudited lnaudited Audited I Revenue from operations 613 15 959 6~ 1,023 19 1,572 79 1.887 10 3 95610 II Other operating income 101 59 101 58 100 43 103 17 100 84 405 16 Ill Other Income 42 41 43 57 70 01 85 98 128 86 230 90 IV Total Income (1+11+111) 757.15 1.104.79 1,193.64 1.86!.94 2.216.80 ~,592.26 v Etpenses a) Cost ofmalerials consumed b) Purchase of Stock-in-Trade - - - - c) Changes in in\entories of fimshed goods work-in-progress and stock-in-trade d) Employee benefit expenses 469 30 491 63 380 44 960 93 733 99 1.551 79 e) Depreciation and amonization expense 181 53 190 13 17810 371 76 355 57 711 34 t) Other expenses H841 483 00 514 I 5 931 41 878 70 1.889 72 1·ou'l t'KIJC'n~r.' 1.099.2~ 1.164.86 1,072.79 2.264.10 1,968.26 ~.153.85 VI ProfiU(Los.s) before exception.al ilems and la:a. 1V-V) (342.09) (60.07) 120.85 (402 -.16 248.54 438AI VII Exceptional items (Refer ~ole-6 & 9 ) 4 97 4 97 ( 19 51) Vlll ProfiU(Lossl berore lax (VI-VII) . (3~2.09) (60.07) 125.82 (402.16) 253. [Showing first 8,000 characters — download PDF for full document]